Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications

Atrophy patterns on MRI can reliably predict three neuropathological subtypes of Alzheimer’s disease (AD): typical, limbic-predominant, or hippocampal-sparing. A method to enable their investigation in the clinical routine is still lacking. We aimed to (1) validate the combined use of visual rating scales for identification of AD subtypes; (2) characterise these subtypes at baseline and over two years; and (3) investigate how atrophy patterns and non-memory cognitive domains contribute to memory impairment. AD patients were classified as either typical AD (n = 100), limbic-predominant (n = 33), or hippocampal-sparing (n = 35) by using the Scheltens’ scale for medial temporal lobe atrophy (MTA), the Koedam’s scale for posterior atrophy (PA), and the Pasquier’s global cortical atrophy scale for frontal atrophy (GCA-F). A fourth group with no atrophy was also identified (n = 30). 230 healthy controls were also included. There was great overlap among subtypes in demographic, clinical, and cognitive variables. Memory performance was more dependent on non-memory cognitive functions in hippocampal-sparing and the no atrophy group. Hippocampal-sparing and the no atrophy group showed less aggressive disease progression. Visual rating scales can be used to identify distinct AD subtypes. Recognizing AD heterogeneity is important and visual rating scales may facilitate investigation of AD heterogeneity in clinical routine.

[1]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[2]  R. Keren,et al.  An exploration of cognitive subgroups in Alzheimer’s disease , 2009, Journal of the International Neuropsychological Society.

[3]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[4]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[5]  F Barkhof,et al.  Qualitative Assessment of Cerebral Atrophy on MRI: Inter- and Intra-Observer Reproducibility in Dementia and Normal Aging , 1997, European Neurology.

[6]  Nick C Fox,et al.  Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele , 2011, The Lancet Neurology.

[7]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[8]  R. Reitan Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[9]  Nick C Fox,et al.  MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases , 2016, Brain : a journal of neurology.

[10]  Medial temporal lobe atrophy scores translated to clinical practice: Editorial comment on ‘Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut‐offs' , 2014, Journal of internal medicine.

[11]  E. Kaplan,et al.  The assessment of aphasia and related disorders , 1972 .

[12]  Nick C Fox,et al.  Revising the definition of Alzheimer's disease: a new lexicon , 2010, The Lancet Neurology.

[13]  G. Chelune,et al.  Education-stratified base-rate information on discrepancy scores within and between the Wechsler Adult Intelligence Scale--Third Edition and the Wechsler Memory Scale--Third Edition. , 2004, Psychological assessment.

[14]  E. Westman,et al.  Different reserve proxies confer overlapping and unique endurance to cortical thinning in healthy middle-aged adults , 2016, Behavioural Brain Research.

[15]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[16]  Julie S. Snowden,et al.  Variability in cognitive presentation of Alzheimer's disease , 2008, Cortex.

[17]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .

[18]  A. Simmons,et al.  Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations , 2015, Neurodegenerative Diseases.

[19]  C. Jack,et al.  Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.

[20]  E. Westman,et al.  Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors. , 2016, Journal of Alzheimer's disease : JAD.

[21]  C. Jack,et al.  Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis , 2011, Neurobiology of Aging.

[22]  M. Masellis,et al.  White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three-City Study , 2016, Alzheimer's & Dementia.

[23]  E. Westman,et al.  Cognitive decline is mediated by gray matter changes during middle age , 2014, Neurobiology of Aging.

[24]  R. Petersen,et al.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.

[25]  Sang Won Seo,et al.  Anatomical heterogeneity of Alzheimer disease , 2014, Neurology.

[26]  Mike P. Wattjes,et al.  Visual assessment of posterior atrophy development of a MRI rating scale , 2011, European Radiology.

[27]  Dong Young Lee,et al.  Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer’s Disease , 2015, PloS one.

[28]  G. Kovacs Clinical stratification of subtypes of Alzheimer's disease , 2012, The Lancet Neurology.

[29]  T. Kurosaki,et al.  Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.

[30]  Christos Davatzikos,et al.  HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework , 2017, NeuroImage.

[31]  Eric Westman,et al.  TheHiveDB image data management and analysis framework , 2014, Front. Neuroinform..

[32]  W. Vach,et al.  Subgroups of Alzheimer's disease: stability of empirical clusters over time. , 2014, Journal of Alzheimer's disease : JAD.

[33]  A. Simmons,et al.  Practical cut‐offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment , 2015, Journal of internal medicine.

[34]  Y. Hong,et al.  Prediction of Alzheimer’s disease pathophysiology based on cortical thickness patterns , 2015, Alzheimer's & Dementia.

[35]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[36]  H. Soininen,et al.  Harmonized diagnostic criteria for Alzheimer's disease: recommendations , 2014, Journal of internal medicine.

[37]  Frederik Barkhof,et al.  Optimizing patient care and research: the Amsterdam Dementia Cohort. , 2014, Journal of Alzheimer's disease : JAD.

[38]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[39]  Frank O. Gehry,et al.  Lou Ruvo Center for Brain Health , 2010 .

[40]  Magda Tsolaki,et al.  Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition , 2016, European Radiology.

[41]  E. Westman,et al.  Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers , 2016, Dementia and Geriatric Cognitive Disorders.

[42]  Masayuki Matsuda,et al.  Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease , 2006, NeuroImage.

[43]  J Marshall,et al.  Cerebral blood flow in dementia. , 1975, Archives of neurology.

[44]  Frederik Barkhof,et al.  The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[45]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .